General Information of the Compound
| Compound ID |
CP0377943
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S,3S,4R)-N-ethyl-3,4-dihydroxy-5-[6-[[4-[methyl(prop-2-enyl)sulfamoyl]phenyl]carbamoylamino]purin-9-yl]oxolane-2-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H28N8O7S
|
||||||||||||||||||
| Molecular Weight |
560.593
|
||||||||||||||||||
| Canonical SMILES |
CCNC(=O)[C@H]1OC([C@H](O)[C@@H]1O)n1cnc2c(NC(=O)Nc3ccc(cc3)S(=O)(=O)N(C)CC=C)ncnc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H28N8O7S/c1-4-10-30(3)39(36,37)14-8-6-13(7-9-14)28-23(35)29-19-15-20(26-11-25-19)31(12-27-15)22-17(33)16(32)18(38-22)21(34)24-5-2/h4,6-9,11-12,16-18,22,32-33H,1,5,10H2,2-3H3,(H,24,34)(H2,25,26,28,29,35)/t16-,17+,18-,22?/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UXZTXTGBYVLFLC-OFRRTHGGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01279, Adenosine receptor A3